The AOP was developed to offer an insight into the molecular mechanism of PXR mediated hypercholesterolemia, since the mechanisms of drug- and chemical-induced hypercholesterolemia are poorly understood. This evidence concerns the gene NR1I2 and familial hypercholesterolemia.